Westlake Genetech
西湖云谷智药
Westlake Genetech (西湖云谷智药) is a Hangzhou-based biotech startup applying artificial intelligence to gene-editing therapeutics, founded in February 2021 by Lijia Ma, a PI at Westlake University's School of Life Sciences and former BGI researcher with a doctorate from the Chinese Academy of Sciences and postdoctoral work at the University of Chicago . The company has built an interdisciplinary team spanning genomics, deep learning, cell biology, and immunology, and developed AIdit, an AI-driven platform for CRISPR-based gene therapy development . Gaorong Ventures led its angel round in 2021 and continued into its Pre-A round . In Gaorong's 2025 coverage, the firm was described as tackling AAV delivery challenges and advancing toward in vivo CAR-T applications .
AI-generated — may contain errors, please verify.
Coverage
Westlake Valley Intelligent Pharma: Cracking the AAV Delivery Challenge with AI, Entering the Super Track of In Vivo CAR-T — Gene Therapy's Moment in China | Gaorong Future
Chinese gene therapies have a real shot at genuine innovation — even leapfrogging the competition.
At the Intersection of Generative AI and Life Sciences: Technology Acceleration on One Side, Clinical Demand on the Other | Ronghui x NVIDIA Inception Program
NVIDIA, Gaorong Ventures, and Cornerstone Robotics on the Acceleration of "AI + Healthcare"
Ma Lijia of Westlake Yungu Intelligence Pharma: AI Knocks on the Door to a Cure for Gene-Editing Therapies | Gaorong Ventures
AI for Science in practice.
New drug development, energy storage, computing, and semiconductors see breakthrough innovations: homegrown R&D, world-first technologies, and AI-driven advances
Constantly creating new possibilities.
Medtech Entrepreneurship Is a "Game for the Brave": How to Sharpen Innovation, Product, and Organizational Capabilities | Ronghui
Discussing trends in medical technology innovation and upgrading R&D team organizational management.
Rongbao · May | Pinduoduo Enters the Era of 800 Million Users, Waterdrop Inc. Debuts on the NYSE
Meeting the needs of China's vast user base for a better life.
Westlake Valley Intelligent Pharma Raises Tens of Millions of RMB in Angel Round, AI Powers Gene-Editing Therapeutics
Dedicated to establishing a complete, end-to-end pipeline for applying AI technology in gene therapy.
